Eledon Pharmaceuticals (ELDN) Financials: Revenue & Earnings

ELDN price $2.50 +0.10 +3.94%

Ticker
ELDN
Price
$2.50
Change
+0.10 +3.94%
Market cap ?
$203.56M
P/E ?
-2.43
Dividend yield ?
0.00%
Beta ?
0.85
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
56
Quality
47
Growth
100

Stocklytics score rationale: value 56, quality 47, growth 100.

Financials

2016201720182019202020212022202320242025
0000000000

Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic candidate, AT-1501, is a humanized monoclonal antibody engineered to specifically target CD40 Ligand, a crucial protein found on the surface…

Fair value

ELDN fair value Not meaningful. Price $2.50.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare ELDN

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-13—-0.20——
2026-08-13-0.27-0.16——
2026-05-13-0.33-0.22——
2026-03-19-0.10-0.20——
2025-11-14-0.21-0.22——
2025-08-14-0.13-0.23——
2025-05-14-0.08-0.28——
2025-03-20-0.64-0.32192.00K—
2024-11-12-0.32-0.30——
2024-08-19-1.06-0.31——
2024-05-09-0.34-0.37——
2024-03-28-0.29-0.38560.00K—
2023-11-09-0.35-0.41——
2023-08-10-0.40-0.47——
2023-05-11-0.75-0.71——
2023-03-30-0.69-0.70——
2022-11-14-0.73-0.68——
2022-08-11-0.65-0.72——
2022-05-12-0.69-0.67——
2022-03-24-0.59-0.83120—
2021-11-11-0.66-0.67——
2021-08-12-0.50-0.58——
2021-05-13-0.57-0.37——
2021-03-30-2.12-1.39120.00K—
2020-11-16-5.51-1.75120.00K—
2020-08-14-2.16-2.97——
2020-05-15-3.42-2.88——
2020-03-17-3.24-4.68——
2019-11-13-3.96-7.29——
2019-08-13-6.30-7.65——
2019-05-14-9.36-8.73——
2019-03-28-8.82-7.20——
2018-11-13-6.66-7.20——
2018-08-07-6.12-5.58——
2018-05-11-6.48-5.22——
2018-04-02-0.90-6.84——
2017-11-08-7.70———
2017-08-09-23.76-48.60——
2017-05-03-27.54-48.60——
2017-03-03-27.54-55.08——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2035-01-10Robinson James A. Jr.Buy30.87K$4.04124.71K
2026-07-31Gros David-Alexandre CBuy354.45K——
2026-07-31Gros David-Alexandre CSell194.79K$3.38658.39K
2026-07-31Perrin StevenBuy152.35K——
2026-07-31Perrin StevenSell72.14K$3.38243.83K
2026-01-10McBride John S.Buy3.43K——
2026-01-10McBride John S.Sell3.43K——
2026-01-10Hillson JanBuy3.43K——
2026-01-10Hillson JanSell3.43K——
2026-01-10Kirk AllanBuy3.43K——
2026-01-10Kirk AllanSell3.43K——
2026-01-10Katkin KeithBuy8.57K——
2026-01-10Katkin KeithSell8.57K——
2026-01-10Lee JuneBuy3.43K——
2026-01-10Lee JuneSell3.43K——
2026-01-10Robinson James A. Jr.Buy3.43K——
2026-01-10Robinson James A. Jr.Sell3.43K——
2025-01-10Hillson JanBuy30.87K$4.04124.71K
2025-01-10Hillson JanBuy3.43K——
2025-01-10McBride John S.Buy30.87K$4.04124.71K
2025-01-10McBride John S.Buy3.43K——
2025-01-10Gros David-Alexandre CBuy600.00K$4.042.42M
2025-01-10Gros David-Alexandre CBuy66.50K——
2025-01-10Little Paul SeanBuy175.00K$4.04707.00K
2025-01-10Little Paul SeanBuy75.00K——
2025-01-10Katkin KeithBuy77.17K$4.04311.79K
2025-01-10Katkin KeithBuy8.57K——
2025-01-10Perrin StevenBuy243.00K$4.04981.72K
2025-01-10Smith Bryan E.Buy150.50K$4.04608.02K
2025-01-10Smith Bryan E.Buy64.50K——
2025-01-10Perrin StevenBuy27.00K——
2025-01-10Lee JuneBuy30.87K$4.04124.71K
2025-01-10Lee JuneBuy3.43K——
2025-01-10Robinson James A. Jr.Buy3.43K——
2025-01-10Kirk AllanBuy30.87K$4.04124.71K
2025-01-10Kirk AllanBuy3.43K——
2024-11-21Little Paul SeanBuy525.03K$2.301.21M
2024-11-21Perrin StevenBuy840.44K$2.301.93M
2024-11-21Smith Bryan E.Buy474.35K$2.301.09M
2024-11-21Gros David-Alexandre CBuy1.02M$2.302.34M
2024-10-29BVF PARTNERS L P/ILBuy2.21M$0.002.21K
2024-10-29BVF PARTNERS L P/ILBuy2.10M$0.002.10K
2024-10-29BVF PARTNERS L P/ILBuy440.49K$0.00440
2024-06-13Gros David-Alexandre CBuy517.45K$2.301.19M
2024-06-13Little Paul SeanBuy267.47K$2.30615.18K
2024-06-13Perrin StevenBuy428.15K$2.30984.74K
2024-06-13Smith Bryan E.Buy241.65K$2.30555.79K
2024-05-09BVF PARTNERS L P/ILBuy1.03M$2.372.44M
2024-05-09BVF PARTNERS L P/ILBuy3.17M$0.003.17K
2024-05-09BVF PARTNERS L P/ILBuy821.12K$2.371.95M
2024-05-09BVF PARTNERS L P/ILBuy2.53M$0.002.53K
2024-05-09BVF PARTNERS L P/ILBuy232.07K$0.00232
2024-05-09BVF PARTNERS L P/ILBuy75.43K$2.37178.77K
2023-10-02Robinson James A. Jr.Buy150.44K$1.55233.18K
2023-10-02Kirk AllanBuy150.44K$1.55233.18K
2023-10-02Kirk AllanOther0——
2023-10-01Robinson James A. Jr.Other0——
2023-05-05BVF PARTNERS L P/ILBuy3.08M$3.009.25M
2023-05-05BVF PARTNERS L P/ILBuy2.45M$3.007.34M
2023-05-05BVF PARTNERS L P/ILBuy1.06M$2.312.44M
2023-05-05BVF PARTNERS L P/ILBuy2.03M$0.002.03K
2023-05-05BVF PARTNERS L P/ILBuy837.15K$2.311.93M
2023-05-05BVF PARTNERS L P/ILBuy1.61M$0.001.61K
2023-05-05BVF PARTNERS L P/ILBuy252.29K$3.00756.87K
2023-05-05BVF PARTNERS L P/ILBuy165.95K$0.00166
2023-05-05BVF PARTNERS L P/ILBuy86.34K$2.31199.45K
2023-05-05BVF PARTNERS L P/ILBuy1.06M——
2023-05-05BVF PARTNERS L P/ILBuy837.15K——
2023-05-05BVF PARTNERS L P/ILBuy86.34K——
2023-05-01Smith Bryan E.Buy179.00K$2.30411.70K
2023-05-01Perrin StevenBuy317.15K$2.30729.44K
2023-05-01Gros David-Alexandre CBuy383.30K$2.30881.59K
2023-05-01Ogier Walter CBuy150.44K$2.30346.01K
2023-05-01Little Paul SeanBuy198.13K$2.30455.69K
2023-05-01Katkin KeithBuy752.18K$2.301.73M
2023-05-01McBride John S.Buy150.44K$2.30346.01K
2023-05-01LYONS GARY ABuy150.44K$2.30346.01K
2023-05-01Lee JuneBuy150.44K$2.30346.01K
2023-05-01Hillson JanBuy150.44K$2.30346.01K
2023-02-01Perrin StevenBuy155.00K$3.08477.40K
2023-02-01Ogier Walter CBuy20.00K$3.0861.60K
2023-02-01McBride John S.Buy20.00K$3.0861.60K
2023-02-01LYONS GARY ABuy20.00K$3.0861.60K
2023-02-01Lee JuneBuy20.00K$3.0861.60K
2023-02-01Katkin KeithBuy20.00K$3.0861.60K
2023-02-01Hillson JanBuy20.00K$3.0861.60K
2023-02-01Gros David-Alexandre CBuy300.00K$3.08924.00K
2023-02-01Gros David-Alexandre CBuy153.60K$3.97609.79K
2023-02-01Smith Bryan E.Buy155.00K$3.08477.40K
2023-02-01Little Paul SeanBuy155.00K$3.08477.40K
2022-11-23Perrin StevenBuy1.00K$2.602.60K
2022-02-01Gros David-Alexandre CBuy108.00K$3.97428.76K
2022-02-01Smith Bryan E.Buy120.00K$3.97476.40K
2022-02-01Perrin StevenBuy155.00K$3.97615.35K
2022-02-01Ogier Walter CBuy20.00K$3.9779.40K
2022-02-01McBride John S.Buy20.00K$3.9779.40K
2022-02-01LYONS GARY ABuy20.00K$3.9779.40K
2022-02-01Lee JuneBuy20.00K$3.9779.40K
2022-02-01Katkin KeithBuy20.00K$3.9779.40K
2022-02-01Hillson JanBuy20.00K$3.9779.40K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 169, holders +46 vs prior quarter. Ownership 41.92%.

HolderSharesChangeChange %Value
BVF INC/IL6.29M00.00%24.80M
BLACKROCK, INC.5.12M741.60K+16.92%20.19M
DEFILADE CAPITAL MANAGEMENT, L.P.3.53M-38.79K-1.09%13.89M
VANGUARD CAPITAL MANAGEMENT LLC3.42M124.09K+3.77%13.46M
GOLDMAN SACHS GROUP INC2.51M2.14M+578.30%9.89M
ENSIGN PEAK ADVISORS, INC2.10M-363.69K-14.75%8.28M
GEODE CAPITAL MANAGEMENT, LLC1.96M164.82K+9.20%7.71M
CATALIO CAPITAL MANAGEMENT, LP1.70M55.26K+3.37%6.68M
STATE STREET CORP1.62M467.30K+40.47%6.39M
ZIMMER PARTNERS, LP1.60M-278.40K-14.85%6.29M
SPHERA FUNDS MANAGEMENT LTD.1.19M-580.94K-32.78%4.69M
AWM INVESTMENT COMPANY, INC.1.10M00.00%4.33M
UBS GROUP AG1.05M500.80K+91.48%4.13M
KINGDON CAPITAL MANAGEMENT, L.L.C.1.04M00.00%4.09M
MILLENNIUM MANAGEMENT LLC979.71K979.71KNew3.86M
BANK OF AMERICA CORP /DE/883.10K13.55K+1.56%3.48M
ADAR1 CAPITAL MANAGEMENT, LLC647.81K-326.61K-33.52%2.55M
22NW, LP636.36K00.00%2.51M
NORTHERN TRUST CORP616.40K72.56K+13.34%2.43M
AQR CAPITAL MANAGEMENT LLC581.03K408.61K+236.99%2.29M
CM MANAGEMENT, LLC575.00K-75.00K-11.54%2.27M
BLUE OWL CAPITAL HOLDINGS LP566.51K-853.40K-60.10%2.23M
DIMENSIONAL FUND ADVISORS LP538.74K471.66K+703.12%2.12M
VANGUARD PORTFOLIO MANAGEMENT LLC533.37K103.48K+24.07%2.10M
VANGUARD FIDUCIARY TRUST CO528.96K25.20K+5.00%2.08M

Earnings and financials

Eledon Pharmaceuticals, Inc. (ELDN) trades at $2.50, with a market cap of $203.56M and a trailing P/E of -2.43. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
0000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Eledon Pharmaceuticals (ELDN) Financials: Revenue & Earnings

ELDN$2.50+0.10 +3.94%

$203.56M

Market Cap

-2.43

P/E

—

Forward P/E

68

Score

Price History